The Role of Atomoxetine for Parkinson Disease–Related Executive Dysfunction: A Systematic Review

Conclusions Based on the reviewed literature, atomoxetine continues to be a therapy of interest for the treatment of executive dysfunction in patients with Parkinson disease. Larger long-term trials are necessary to further define the role of atomoxetine for patients with Parkinson disease–related executive dysfunction.
Source: Journal of Clinical Psychopharmacology - Category: Psychiatry Tags: Review Articles Source Type: research